NPP BrainPod

Validation of L-type calcium channel blocker amlodipine as a novel ADHD treatment through cross-species analysis, drug-target Mendelian randomization, and clinical evidence from medical records


Listen Later

Attention deficit hyperactivity disorder, or ADHD, is a common condition that, for a lot of people, is difficult to treat. The drugs that exist have a number of adverse side effects, and about 25 percent of patients don’t respond to existing drugs. And so a team of researchers in Iceland, led by Karl Karlsson, professor of biomolecular engineering at Reykjavik University, undertook a number of different steps to narrow in on and then test what the team has determined to be a novel treatment for ADHD, using an existing drug, amlodipine. 


Read the full study here: https://www.nature.com/articles/s41386-025-02062-x

Hosted on Acast. See acast.com/privacy for more information.

...more
View all episodesView all episodes
Download on the App Store

NPP BrainPodBy Springer Nature

  • 4
  • 4
  • 4
  • 4
  • 4

4

15 ratings


More shows like NPP BrainPod

View all
Nature Podcast by Springer Nature Limited

Nature Podcast

752 Listeners

Economist Podcasts by The Economist

Economist Podcasts

4,275 Listeners

Eye Podcast by Nature Publishing Group

Eye Podcast

0 Listeners

Pediatric Research Podcast by Nature Publishing Group

Pediatric Research Podcast

4 Listeners

Science Vs by Spotify Studios

Science Vs

12,074 Listeners

The Daily by The New York Times

The Daily

111,785 Listeners

The Rest Is History by Goalhanger

The Rest Is History

12,918 Listeners